Drug reference
fomivirsen
Antisense oligonucleotide · Antiviral (Anti-CMV)
Antisense oligonucleotideAntiviral (Anti-CMV)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Fomivirsen is a 21-base phosphorothioate oligonucleotide that provides antisense therapy. It is complementary to the mRNA sequence for the major immediate-early transcriptional region of CMV and inhibits CMV replication through sequence-specific and nonspecific mechanisms, including inhibition of virus binding to cells.
Indications
CMV retinitis (for patients intolerant of or unresponsive to other therapies, and in HIV-infected patients with refractory, sight-threatening CMV retinitis)CMV retinitis (injected into vitreous humor)
Pharmacokinetics
Half-life
~55 h (vitreous)
Side effects
Common
iritis (up to one-quarter of patients)vitritiscataractsincreases in intraocular pressure (15% to 20%)ocular complications
Related guidelines
Ask House about fomivirsen
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team